Search
for
Sort by
Research 91–120 of 345
- Dermatologic Reactions to Targeted Therapy
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Acneiform Rash Caused by an Unlikely Drug: Topiramate
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Cutaneous manifestations associated with COVID-19 infection at a university hospital in eastern China
- The Impact of Covid-19 Pandemic on the Clinical Course of Pediatric Skin Disorders: A Cross-Sectional Study
- General Dermatology
- LUPUS ERYTHEMATOSUS AND THE SKIN
- The Skin and Subcutaneous Tissues
- British Society for Dermatopathology: Summaries of Papers
- Clinico-Pathological Profile of Cutaneous Lupus Erythematosus Patients: A Report from A Tertiary Care Center of Chattogram
- Cutaneous reactions to recombinant cytokine therapy
- Advances in the Management of Cutaneous Toxicities of Targeted Therapies
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Skin signs of systemic diseases
- Hair loss
- Skin manifestations of endocrine diseases
- Scalp Sarcoidosis with Systemic Involvement: A Case Report and Literature Review
- Atlas of Geriatric Dermatology
- Case Report: Secondary syphilitic alopecia following non-penetrative sexual contact: a case of initial misdiagnosis
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Dermatological adverse events with taxane chemotherapy
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
- Graft-versus-host disease